Search Results

Recent Findings in Rhabdomyolysis Described by Researchers from University of Toledo (Rhabdomyolysis and Acute Kidney Injury Potentiated By a Drug-drug Interaction Between Cyclosporine, Leflunomide, and Rosuvastatin In a Kidney Transplant...).

Subjects: KIDNEY transplantation; ACUTE kidney failure; ROSUVASTATIN

• Source: Drug Week; 6/21/2024, p358-358, 1p

Record details

Resveratrol attenuates cyclosporin A-induced upregulation of the thromboxane A2 receptor and hypertension via the AMPK/SIRT1 and MAPK/NF-κB pathways in the rat mesenteric artery.

• Authors : Li, Qian¹ (AUTHOR); Cao, Hanjing¹ (AUTHOR); Xu, Xinya^1,2 (AUTHOR)

Subjects: *RESVERATROL; *MESENTERIC artery; *CYCLOSPORINE

• Source: European Journal of Pharmacology. Jun2024, Vol. 972, pN.PAG-N.PAG. 1p.

Record details

Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.

• Authors : Galgoczi, Erika¹ (AUTHOR) ; Molnar, Zsanett¹ (AUTHOR) ; Katko, Monika¹ (AUTHOR)

Subjects: *CYCLOSPORINE; *HYALURONIC acid; *FIBROBLASTS

• Source: Chemico-Biological Interactions. Jun2024, Vol. 396, pN.PAG-N.PAG. 1p.

Record details

LC-MS/MS and EMIT measure the whole blood concentration of cyclosporine A: The two methods yield concordant results within the dynamic range of the latter, but the former shows broader application scenarios.

• Authors : Zhang, Yuan-Yuan¹ (AUTHOR); Guo, Hong-Li¹ (AUTHOR); Wang, Jie¹ (AUTHOR)

Subjects: *LIQUID chromatography-mass spectrometry; *DRUG monitoring; *POISONS

• Source: Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences. Jun2024, Vol. 1240, pN.PAG-N.PAG. 1p.

Record details

Cyclosporine-induced kidney damage was halted by sitagliptin and hesperidin via increasing Nrf2 and suppressing TNF-α, NF-κB, and Bax.

• Authors : Abd-Eldayem AM; Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt. .; Department of Pharmacology, Faculty of Medicine, Merit University, Sohâg, Egypt. .

Subjects: Hesperidin*/Hesperidin*/Hesperidin*/pharmacology ; Hesperidin*/Hesperidin*/Hesperidin*/therapeutic use ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/chemically induced

• Source: Scientific reports [Sci Rep] 2024 Mar 28; Vol. 14 (1), pp. 7434. Date of Electronic Publication: 2024 Mar 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers.

• Authors : Zhao, Xuemei¹ (AUTHOR) ; Zhao, Xin¹ (AUTHOR) ; Di, Weihua¹ (AUTHOR)

Subjects: *CYCLOPHILINS; *CYCLOSPORINE; *PEPTIDES

• Source: Molecules. Mar2024, Vol. 29 Issue 6, p1235. 24p.

Record details

Ciclosporin/cyclophosphamide: Various toxicites.

Subjects: *CYCLOSPORINE; *CYCLOPHOSPHAMIDE; *CONGENITAL disorders

• Source: Reactions Weekly. 1/20/2024, Vol. 1991 Issue 1, p68-68. 1p.

Record details

Modeled microgravity unravels the roles of mechanical forces in renal progenitor cell physiology.

• Authors : Melica ME; Department of Clinical and Experimental Biomedical Sciences 'Mario Serio', University of Florence, Viale Morgagni 50, 50134, Florence, Italy.; Cialdai F

Subjects: Weightlessness* ; Podocytes* ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/metabolism

• Source: Stem cell research & therapy [Stem Cell Res Ther] 2024 Jan 17; Vol. 15 (1), pp. 20. Date of Electronic Publication: 2024 Jan 17.Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512

Record details

Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting.

• Authors : Shimada, Tsutomu; Kawakami, Daisuke; Fujita, Arimi

Subjects: CYCLOSPORINE; TACROLIMUS; IMMUNOASSAY

• Source: Journal of Pharmaceutical Health Care & Sciences; 1/8/2024, Vol. 10 Issue 1, p1-7, 7p

Record details

Multitarget therapy with a corticosteroid, cyclosporine and mycophenolate mofetil for idiopathic membranous nephropathy: a prospective randomized controlled trial.

• Authors : Duan, Yajuan¹ (AUTHOR); Bai, Yu¹ (AUTHOR); Guo, Weikang¹ (AUTHOR)

Subjects: *MYCOPHENOLIC acid; *RANDOMIZED controlled trials; *CYCLOSPORINE

• Source: Nephrology Dialysis Transplantation. Jan2024, Vol. 39 Issue 1, p95-102. 8p.

Record details